Table 2.
Clinical outcomes
Variables | PCM group (n = 52) | Control group (n = 61) | P value |
---|---|---|---|
Encephalopathy score (Thompson score) | |||
Day 1, Mean, min–max | 16 (9 – 21) | 17 (9 – 22) | n.s |
At discharge, Mean, min–max | 5 (0 – 18) | 6 (0 – 18) | n.s |
Complications during cooling – no. (%) | |||
Hypotension ± inotropes | 30 (58) | 33 (54) | n.s |
Pneumothorax | 2 (4) | 0 | n.s |
Uncontrollable seizures | 4 (8) | 3 (5) | n.s |
Sepsis | 10 (19) | 10 (16) | n.s |
MRI at day 7–10 – no. (%) | |||
White matter injury | 10 (19) | 11 (18) | n.s |
Cerebral hemorrhage | 3 (6) | 1 (2) | n.s |
Brain edema | 2 (4) | 1 (2) | n.s |
Brain atrophy | 0 | 1 (2) | n.s |
Deaths – n (%) | |||
Total | 17 (33%) | 21 (34%) | n.s |
Sarnat stage II | 2 | 3 | n.s |
Sarnat stage III | 15 | 18 | n.s |